6 min. Read

Roche VR autism DTx. Pear pre-FDA launch. Welldoc reunion.

Issue 050.

Get E&O weekly. Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a 58 percent open rate. Here's what's happening this week:

  • I received some great responses to last week's The Hinge Health Report, so I'll have some more on the digital MSK market in next week's newsletter.
  • Speaking of MSK, the latest COVID--19-related regulatory rollback from CMS allows physical therapists and others to bill Medicare for services rendered via telehealth. More here.
  • Meanwhile, HHS's Secretary's Advisory Committee on Human Research Protections (SACHRP) suggested more regulations are needed for requirements around using digital health technologies in medical research. Dig in here.
  • Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) offered up a paper on what a Cures 2.0 Act might cover. Notably, their working paper mentions "digital

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Cigna bought MDLIVE for $2B cash in 2021
6 min. Read
Pear bought Pear. New HCPCS attempts. Trials
8 min. Read
Pear sold for $6M. Woebot pauses PDTs. Swing-FDA
6 min. Read
Quest bought Pack Health for $123M cash. Trials
6 min. Read
New digital health CPT code hopefuls. Trials
5 min. Read
Breaking: Pear Therapeutics files for Chapter 11 bankruptcy
4 min. Read
Pricing Database update: 60+ digital health prices.
3 min. Read
E&O readers analyze fate of Pear, PDTs. FDA-AI
8 min. Read
Seven secret health tech funding deals
3 min. Read
FDA waiver ends Nov 7. Withings ScanWatch recall, revs
10 min. Read
  • First
  • Previous
  • 1 of 32
  • Next
  • Last